
Aileron Therapeutics Inc a clinical-stage biopharmaceutical company. It is focused on developing a novel class of therapeutics for the treatment of cancer and other diseases. The company's lead product candidate, ALRN-6924 is a novel chemoprotective medicine to treat and protect healthy cells in pat... Aileron Therapeutics Inc a clinical-stage biopharmaceutical company. It is focused on developing a novel class of therapeutics for the treatment of cancer and other diseases. The company's lead product candidate, ALRN-6924 is a novel chemoprotective medicine to treat and protect healthy cells in patients with cancer that harbors p53 mutations to reduce or eliminate chemotherapy-induced side effects. 더 보기
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 2.11 | 2.11 | 2.11 | 0 | 0 | CS |
4 | 0 | 0 | 2.11 | 2.11 | 2.11 | 0 | 0 | CS |
12 | -0.14 | -6.22222222222 | 2.25 | 2.4 | 1.93 | 23747 | 2.21075054 | CS |
26 | -0.83 | -28.231292517 | 2.94 | 4.4 | 1.69 | 58792 | 2.86504002 | CS |
52 | -3.28 | -60.853432282 | 5.39 | 7.42 | 1.61 | 73689 | 3.41880225 | CS |
156 | -6.508 | -75.5163611047 | 8.618 | 15 | 1.01 | 200703 | 5.01637271 | CS |
260 | -5.89 | -73.625 | 8 | 49.4 | 1.01 | 580213 | 23.47154242 | CS |
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관